Skye Bioscience’s Developing Treatment for Glaucoma Daily Download February 22, 2023 Share FacebookTwitterPinterestWhatsApp Embed Code Disclaimer Join us for a discussion about Skye Bioscience’s developing treatment for glaucoma using a synthetic cannabinoid. Our guest, CEO of Skye Bioscience, Punit Dhillon, breaks down this new innovation further with our guest Alicia Nieves. Related posts: Speculation Growing Over Uses for ChatGPT AI Sweater Aiming to Make Venture Capital More Accessible SEC Cracks Down on Kraken Exploring The Future Of The Metaverse Advertisement Latest articles Energy sector investments shifting as Trump admin. aims for U.S. dominance Market Movers: The Opening Bell March 24, 2025 Markets higher to open last full trading week of March Market Movers: The Opening Bell March 24, 2025 Germany’s defense spending leading to E.U. debt concerns Market Movers: The Opening Bell March 24, 2025 Optty partners with ekko to simplify sustainable payment solutions for business Market Movers: The Opening Bell March 24, 2025 Related articles Energy sector investments shifting as Trump admin. aims for U.S. dominance Market Movers: The Opening Bell March 24, 2025 Markets higher to open last full trading week of March Market Movers: The Opening Bell March 24, 2025 Germany’s defense spending leading to E.U. debt concerns Market Movers: The Opening Bell March 24, 2025